HIV PrEP Update – Expression of Interest
This is an Expression of Interest page. By clicking “Register Now” your name will be added to a wait list. You will be notified to register via email when a session becomes available in your state of residence or practice. Learning Outcomes • Describe HIV epidemiology in Australia and the different HIV prevention strategies. • Explain the […]
Introduction to PrEP Prescribing
This introduction to PrEP Prescribing online learning module has been developed to provide clinicians with an understanding of PrEP, including assessing a patient’s suitability for PrEP, how to prescribe it, and how to engage in ongoing monitoring of patients taking PrEP. It is intended for medical practitioners and nurse practitioners intending to prescribe PrEP, but […]
PrEP Dosing Guide
The PrEP dosing guide is intended to help clinicians in making the decision whether daily PrEP or on-demand PrEP is suitable for the patient.This resource also gives examples of the different dosing options and explains how to prescribe it.
Decision Making In PrEP – NSW
This 2-page Decision Making in PrEP: Prescribing Pathway for PrEP in NSW tool summarises the key eligibility and recommended assessment criteria for primary care providers in NSW who wish to prescribe PrEP, as well as outlining ongoing patient education and monitoring requirements. For expanded details, see the ASHM PrEP Clinical Guidelines.
Highlights from HIV&AIDS 2024 and the 25th IUSTI World Congress
In September 2024, ASHM delivered two landmark conferences at ICC Sydney on Gadigal Country: the Australasian HIV&AIDS Conference 2024 and 25th IUSTI World Congress (incorporating the Australasian Sexual and Reproductive Health Conference). Together, these conferences united over 1,200 delegates from 35 countries over 5 days to discuss the latest advancements in HIV and sexual and […]
Implementing long-acting injectable HIV PrEP: Recommendations to support the Australian health sector
On the 6th of April 2024, ASHM Health organised a national workshop, funded by ViiV Healthcare, to convene a select group of key stakeholders from each Australian state and territory. The primary objective was to facilitate discussions around how to successfully implement the use of long-acting injectable cabotegravir (CAB-LA) as HIV PrEP throughout Australia and to identify […]
Medications used for HIV Pre-Exposure Prophylaxis (PrEP) experiencing supply shortages in Australia
As of 9 September 2024, Australia is currently experiencing a supply shortage of medications containing tenofovir and emtricitabine, which are commonly used for HIV Pre-Exposure Prophylaxis (PrEP). Despite this shortage, pharmacists, HIV PrEP prescribers, and people using HIV PrEP should not be alarmed — shortages are expected to resolve later this year for most brands. Current impact […]
Budget announcement marks major investment in HIV, BBVs and STIs
ASHM welcomes news from the federal budget of a $126.5 million investment over two years to support the prevention, testing and treatment of blood-borne viruses (BBVs) and STIs, alongside a $43.9 million investment to implement the recommendations of the HIV Taskforce. This announcement represents a significant investment by the federal government in the national response […]
Preparing for PrEP in Papua New Guinea
Pre-Exposure Prophylaxis (PrEP) has been a game changer for HIV prevention. In Australia, biomedical HIV prevention strategies, including PrEP and treatment as prevention, have been instrumental in the significant declines in HIV transmission we have seen over the last ten years. However, rolling out a drug regime like PrEP can be complex. And while […]
Stigma and discrimination, no place in healthcare.
Stigma and discrimination, no place in healthcare. These resources serve as a guide and support for healthcare professionals seeking to understand and address the impact of stigma and discrimination on patient care. Our materials cover best practices for creating inclusive healthcare environments, identification and mitigation of bias, and relevant research and literature on the topic. […]
